Results 141 to 150 of about 23,901 (228)

Timing of Denosumab Therapy in Relation to Parathyroidectomy in the Setting of Primary Hyperparathyroidism: Case Report

Case Reports in Endocrinology
The optimal timing of denosumab therapy in relation to parathyroid surgery to avoid hypocalcemia and rebound bone resorption is not well described. Herein we report the case of a 62-year-old woman with steroid-induced osteoporosis who received denosumab ...
Ryan S. MacLeod, Adriana Ramirez, Barbara Gulanski, Sachin K. Majumdar   +3 more
doaj   +1 more source

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors

, 2012
Ursa Brown-Glaberman, Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USAAbstract: Skeletal-related events (SREs) including pain, fractures, and hypercalcemia are a major source of morbidity for cancer patients with bone metastases.
Stopeck AT, Brown-Glaberman U
core  

Prescribing Trends of Osteoporosis Medications, Adherence and Persistence with Denosumab versus Alendronate: A Real-World Retrospective Study in China. [PDF]

Patient Prefer Adherence
Chen J, Huang Y, Liu P, Fan L.
europepmc   +1 more source

Case Report: Reopening the anabolic window - romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients. [PDF]

Front Endocrinol (Lausanne)
Barbuto S, Mastromauro P, Zavatta G, Vetrano D, Mistretta A, Bisceglia N, Comai G, Pagotto U, La Manna G, Cianciolo G.   +9 more
europepmc   +1 more source

An osteogenic microenvironment improves response during denosumab treatment in giant cell tumors of bone in the spine. [PDF]

Front Med (Lausanne)
Birch R, Eltit F, Ng T, Rhines LD, Gokaslan ZL, Dea N, Fisher CG, Cox ME, Wang R, Charest-Morin R.   +9 more
europepmc   +1 more source

Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland. [PDF]

Clin Oral Investig
Kujanpää M, Vuollo V, Tiisanoja A, Laitala ML, Koivunen J, Sándor GK, Karki S.   +6 more
europepmc   +1 more source

Medication-related osteonecrosis of the external auditory canal and treatment with teriparatide. [PDF]

JCEM Case Rep
Xia D, Ting MJM, Atlas MD, Boeddinghaus R, Stuckey BGA.   +4 more
europepmc   +1 more source

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment

, 2018
Yukio Nakamura,1,2 Mikio Kamimura,3 Akio Morikawa,4 Akira Taguchi,5 Takako Suzuki,1 Hiroyuki Kato1 1Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, 2Department of Orthopedic Surgery, Showa-Inan General Hospital ...
Kamimura M, Kato H, Suzuki T, Morikawa A, Nakamura Y, Taguchi A   +5 more
core  

Osteoporosis treatment with biosimilars in Malaysia and Thailand: a budget impact analysis. [PDF]

Arch Osteoporos
Siachalinga L, Jones A, Kim K, Downes M, Solev I, Lee K, Valleenukul T, Kim H.   +7 more
europepmc   +1 more source

Role of Denosumab in Chronic Kidney Disease with Paget's Disease of Bone: A Case Report and Review of Literature. [PDF]

J Orthop Case Rep
Totaganti M, Suryadevara V, Raju S, Sahoo J, Naik D, Kamalanathan S.   +5 more
europepmc   +1 more source